Although the change from baseline in albumin level was not significant at 3 years post-HCC treatment, the albumin level in the DAA group showed an improving trend (p = 0.068), whereas that in the untreated group showed a significant decline (p = 0.002). Here, ALB is linked to hepatocellular carcinoma.